Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1959 May;35(403):248–255. doi: 10.1136/pgmj.35.403.248

Oral Hypoglycaemic Drugs

J D H Slater
PMCID: PMC2501957  PMID: 13657801

Full text

PDF
248

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ACKERMAN I. P., CONN J. W., FAJANS S. S., GITTLER R. D., HENNES A. R., JOHNSON R. D., LOUIS L. H., SELTZER H. S., WAJCHENBERG B. L. Metabolic effects of arylsulfonylurea compounds in normal men and in diabetic subjects. Metabolism. 1956 Nov;5(6 Pt 2):820–839. [PubMed] [Google Scholar]
  2. ARAI Y., ELRICK H., HLAD C., Jr, PRATT E., PURNELL R. Some observations on the mode of action of orinase. Metabolism. 1956 Nov;5(6 Pt 2):778–787. [PubMed] [Google Scholar]
  3. ASHMORE J., CAHILL G. F., Jr, HASTINGS A. B. Inhibition of glucose-6-phosphatase by hypoglycemic sulfonylureas. Metabolism. 1956 Nov;5(6 Pt 2):774–777. [PubMed] [Google Scholar]
  4. ASHWORTH M. A., HAIST R. E. Some effects of BZ-55 (carbutamide) on the growth of the islets of Langerhans. Can Med Assoc J. 1956 Jun 15;74(12):975–976. [PMC free article] [PubMed] [Google Scholar]
  5. BAIRD J. D., DUNCAN L. J. An analysis of the hypoglycaemic response to tolbutamide. Scott Med J. 1957 Sep;2(9):341–350. doi: 10.1177/003693305700200901. [DOI] [PubMed] [Google Scholar]
  6. BEASER S. B. Further experience with the use of sulfonylureas in diabetes. Ann N Y Acad Sci. 1957 Jul 10;71(1):264–267. [PubMed] [Google Scholar]
  7. BERTHET J., MAKMAN M. H., SUTHERLAND E. W. Observations on the action of certain sulfonylurea derivatives. Metabolism. 1956 Nov;5(6 Pt 2):768–773. [PubMed] [Google Scholar]
  8. BRITTON B., GRABOWSKI R., WICK A. N. The action of a sulfonylurea hypoglycemic agent (orinase) in extrahepatic tissues. Metabolism. 1956 Nov;5(6 Pt 2):739–743. [PubMed] [Google Scholar]
  9. BUTTERFIELD J., FRY I. K., HOLLING E. Effects of insulin, tolbutamide and phenethyldiguanidine on peripheral glucose uptake in man. Diabetes. 1958 Nov-Dec;7(6):449–454. doi: 10.2337/diab.7.6.449. [DOI] [PubMed] [Google Scholar]
  10. BUTTERFIELD W. J., THOMPSON R. H. The effect of dimercaprol (BAL) on blood sugar and pyruvate levels in diabetes mellitus. Clin Sci. 1957 Nov;16(4):679–694. [PubMed] [Google Scholar]
  11. Best C. H., Haist R. E., Ridout J. H. Diet and the insulin content of pancreas. J Physiol. 1939 Nov 14;97(1):107–119. doi: 10.1113/jphysiol.1939.sp003793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. CAMPBELL J., HAUSLER H. R., MUNROE J. S., DAVIDSON I. W. Effects of growth hormone in dogs. Endocrinology. 1953 Aug;53(2):134–162. doi: 10.1210/endo-53-2-134. [DOI] [PubMed] [Google Scholar]
  13. CLARKE D. W., DAVIDSON M., SCHONBAUM E., SENMAN H. Some in vitro studies with BZ-55. Can Med Assoc J. 1956 Jun 15;74(12):966–968. [PMC free article] [PubMed] [Google Scholar]
  14. CREUTZFELDT W., DETERING L., WELTE O. Das B-Zellensystem von normalen und hypophysektomierten Ratten sowie von Kaninchen unter D 860 und diabetogenen Hormonen. Dtsch Med Wochenschr. 1957 Sep 6;82(36):1564–1568. doi: 10.1055/s-0028-1116937. [DOI] [PubMed] [Google Scholar]
  15. DOLGER H. Experience with the tolbutamide treatment of five hundred cases of diabetes on an ambulatory basis. Ann N Y Acad Sci. 1957 Jul 10;71(1):275–279. [PubMed] [Google Scholar]
  16. DUNCAN G. G., LEE C. T., YOUNG J. K. Clinical experiences with the sulfonylurea compounds. Ann N Y Acad Sci. 1957 Jul 10;71(1):233–238. [PubMed] [Google Scholar]
  17. FOA P. P., GALANSINO G., POZZA G. Insulin secretion following carbutamide injections in normal dogs. Proc Soc Exp Biol Med. 1956 Dec;93(3):539–542. doi: 10.3181/00379727-93-22811. [DOI] [PubMed] [Google Scholar]
  18. FRITZ I. B., LEVINE R., MORTON J. V., WEINSTEIN M. Studies on the mechanism of action of the sulfonylureas. Metabolism. 1956 Nov;5(6 Pt 2):744–748. [PubMed] [Google Scholar]
  19. FROESCH E. R., RENOLD A. E., THORN G. W., WINEGRAD A. I. Studies on the site of action of the arylsulfonylureas in man. Metabolism. 1956 Nov;5(6 Pt 2):757–767. [PubMed] [Google Scholar]
  20. GILBERTSEN A. S., GOETZ F. C., JOSEPHSON V. Acute effects of orinase on peripheral glucose utilization. Metabolism. 1956 Nov;5(6 Pt 2):788–800. [PubMed] [Google Scholar]
  21. Gessler C. J., Halsted J. A., Stetson R. P. EFFECT OF ESTROGENIC SUBSTANCE ON THE BLOOD SUGAR OF FEMALE DIABETICS AFTER THE MENOPAUSE. J Clin Invest. 1939 Nov;18(6):715–722. doi: 10.1172/JCI101087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. HOUSSAY B. A., PENHOS J. C. Action of the hypoglycemic sulfonyl compounds in hypophysectomized, adrenalectomized and depancreatized animals. Metabolism. 1956 Nov;5(6 Pt 2):727–732. [PubMed] [Google Scholar]
  23. HUGH-JONES P. Diabetes in Jamaica. Lancet. 1955 Oct 29;269(6896):891–897. doi: 10.1016/s0140-6736(55)92530-7. [DOI] [PubMed] [Google Scholar]
  24. KRALL L. P., CAMERINI-DAVALOS R. Early clinical evaluation of a new oral non-sulfonylurea hypoglycemic agent. Proc Soc Exp Biol Med. 1957 Jun;95(2):345–347. doi: 10.3181/00379727-95-23215. [DOI] [PubMed] [Google Scholar]
  25. LANG S., SHERRY S. Some effects of orinase in the rat. Metabolism. 1956 Nov;5(6 Pt 2):733–738. [PubMed] [Google Scholar]
  26. LUNDBAEK K., NIELSEN K., RAFAELSEN O. J. Mode of action of oral antidiabetic compounds. Lancet. 1958 May 17;1(7029):1036–1038. doi: 10.1016/s0140-6736(58)92004-x. [DOI] [PubMed] [Google Scholar]
  27. MADISON L. L., UNGER R. H. The physiologic significance of the secretion of endogenous insulin into the portal circulation. I. Comparison of the effects of glucagon-free insulin adminstered via the portal vein and via a peripheral vein on the magnitude of hypoglycemia and peripheral glucose utilization. J Clin Invest. 1958 May;37(5):631–639. doi: 10.1172/JCI103646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. MARBLE A., CAMERINI-DAVALOS R. Clinical experience with sulfonylurea compounds in diabetes. Ann N Y Acad Sci. 1957 Jul 10;71(1):239–248. [PubMed] [Google Scholar]
  29. MARBLE A. Oral hypoglycemic agents in the management of diabete. Med Clin North Am. 1958 Sep;42(5):1163–1177. doi: 10.1016/s0025-7125(16)34215-8. [DOI] [PubMed] [Google Scholar]
  30. MIRSKY I. A., PERISUTTI G., GITELSON S. The role of insulinase in the hypoglycemic response to sulfonylureas. Ann N Y Acad Sci. 1957 Jul 10;71(1):103–111. [PubMed] [Google Scholar]
  31. McGAVACK T. H., SEEGERS W., HAAR H. O., ENZINGER J., ERK V. O. Thyroid function of diabetic patients as influenced by the sulfonylureas. Ann N Y Acad Sci. 1957 Jul 10;71(1):268–274. [PubMed] [Google Scholar]
  32. SHERRY S., ZEFFREN J. L., BRAVERMAN A. E., DREY N. W. The use of tolbutamide in the management of adult diabetes. Ann N Y Acad Sci. 1957 Jul 10;71(1):249–255. [PubMed] [Google Scholar]
  33. STICH W., MARX R., EHRHART H. Hamatologie des Diabetes mellitus und Rastinon-Therapie. Dtsch Med Wochenschr. 1957 Sep 6;82(36):1533–1537. doi: 10.1055/s-0028-1116927. [DOI] [PubMed] [Google Scholar]
  34. STOWERS J. M., MAHLER R. F., HUNTER R. B. Pharmacology and mode of action of the sulphonylureas in man. Lancet. 1958 Feb 8;1(7015):278–283. doi: 10.1016/s0140-6736(58)91028-6. [DOI] [PubMed] [Google Scholar]
  35. SUGAR S. J. Use of the sulfonylureas in diabetes mellitus. Ann N Y Acad Sci. 1957 Jul 10;71(1):256–263. [PubMed] [Google Scholar]
  36. UNGAR G., FREEDMAN L., SHAPIRO S. L. Pharmacological studies of a new oral hypoglycemic drug. Proc Soc Exp Biol Med. 1957 May;95(1):190–192. doi: 10.3181/00379727-95-23163. [DOI] [PubMed] [Google Scholar]
  37. VAUGHAN M. In vitro studies on the action of sulfonamide hypoglycemic agents. Science. 1956 May 18;123(3203):885–886. doi: 10.1126/science.123.3203.885. [DOI] [PubMed] [Google Scholar]
  38. VON HOLT C., VON HOLT L., KRACHT J., KRONER B., KUHNAU J. Carbutamide and plasma insulin activity. Science. 1957 Apr 19;125(3251):735–736. doi: 10.1126/science.125.3251.735. [DOI] [PubMed] [Google Scholar]
  39. WALKER G., SLATER J. D., WESTLAKE E. K., NABARRO J. D. Clinical experience with tolbutamide. Br Med J. 1957 Aug 10;2(5040):323–325. doi: 10.1136/bmj.2.5040.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. WEAVER J. A., PROUT T. E., SCOTT G. W., ASPER S. P. Role of insulin in acute hypoglycaemic action of tolbutamide. Br Med J. 1958 Feb 22;1(5068):425–429. doi: 10.1136/bmj.1.5068.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. WEBER G., CANTERO A. Effect of orinase on hepatic enzymes involved in glucose-6-phosphate utilization. Metabolism. 1958 Jul;7(4 Pt 1):333–337. [PubMed] [Google Scholar]
  42. WILLIAMS R. H., TYBERGHEIN J. M., HYDE P. M., NIELSEN R. L. Studies related to the hypoglycemic action of phenethyldiguanide. Metabolism. 1957 Jul;6(4):311–319. [PubMed] [Google Scholar]
  43. WRENSHALL G. A., BEST C. H. Extractable insulin of the pancreas and effectiveness of oral hypoglycaemic sulfonylureas in the treatment of diabetes in man; a comparison. Can Med Assoc J. 1956 Jun 15;74(12):968–972. [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES